Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Modulation of inflammatory mediators and ppargammaand nfkappab expression by pravastatin in response to lipoproteins in human monocytes in vitro.

Zelvyté, Inga LU ; Dominaitiene, Ruta ; Crisby, Milita and Janciauskiene, Sabina LU (2002) In Pharmacological Research 45(2). p.147-154
Abstract
Statins are inhibitors of the rate-limiting step of cellular cholesterol synthesis. In vitro and in vivo studies suggest that statins have anti-inflammatory properties independent of their cholesterol-lowering effects. These observations prompted us to examine the effects of pravastatin (50 mgr; M) and native or oxidized low density lipoprotein (nLDL or oxLDL) (50 mgr; g ml(minus sign1)) on primary human monocytes. We found that cells treated with pravastatin prior to nLDL and cells pre-treated with oxLDL prior to pravastatin showed increased activity of peroxisome proliferator-activated receptor gamma (PPAR gamma). Treatment of cells with drug either before incubation with oxLDL or afterwards suppressed nuclear factor kappa B (NF kappa B)... (More)
Statins are inhibitors of the rate-limiting step of cellular cholesterol synthesis. In vitro and in vivo studies suggest that statins have anti-inflammatory properties independent of their cholesterol-lowering effects. These observations prompted us to examine the effects of pravastatin (50 mgr; M) and native or oxidized low density lipoprotein (nLDL or oxLDL) (50 mgr; g ml(minus sign1)) on primary human monocytes. We found that cells treated with pravastatin prior to nLDL and cells pre-treated with oxLDL prior to pravastatin showed increased activity of peroxisome proliferator-activated receptor gamma (PPAR gamma). Treatment of cells with drug either before incubation with oxLDL or afterwards suppressed nuclear factor kappa B (NF kappa B) expression and reduced uptake of(125)I-oxLDL by 1.7- and 1.5-fold, respectively. Pravastatin also increased PPAR gamma levels and abolished NF kappa B activity in non-stimulated monocytes. Statin added to monocytes prior to or after treatment with nLDL or oxLDL significantly inhibited generation of matrix metalloproteinases (MMPs), monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor alpha (TNF- alpha). These data corroborate previous findings of the pleiotropic role of statins and also suggest the involvement of transcription factors such as PPAR gamma and NF kappa B in the modulation of the inflammatory processes by statins. Copyright 2002 Elsevier Science Ltd. (Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
lipoproteins, monocytes, Monocyte Chemoattractant Protein-1, NF kappa B, pravastatin
in
Pharmacological Research
volume
45
issue
2
pages
147 - 154
publisher
Academic Press
external identifiers
  • wos:000174516100012
  • pmid:11846628
  • scopus:0036445650
ISSN
1096-1186
DOI
10.1006/phrs.2001.0922
language
English
LU publication?
yes
id
53dcbf95-1a5e-40ec-aa32-46cfa9d34397 (old id 106017)
alternative location
http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11846628&dopt=Abstract
date added to LUP
2016-04-01 12:17:06
date last changed
2022-05-07 00:23:35
@article{53dcbf95-1a5e-40ec-aa32-46cfa9d34397,
  abstract     = {{Statins are inhibitors of the rate-limiting step of cellular cholesterol synthesis. In vitro and in vivo studies suggest that statins have anti-inflammatory properties independent of their cholesterol-lowering effects. These observations prompted us to examine the effects of pravastatin (50 mgr; M) and native or oxidized low density lipoprotein (nLDL or oxLDL) (50 mgr; g ml(minus sign1)) on primary human monocytes. We found that cells treated with pravastatin prior to nLDL and cells pre-treated with oxLDL prior to pravastatin showed increased activity of peroxisome proliferator-activated receptor gamma (PPAR gamma). Treatment of cells with drug either before incubation with oxLDL or afterwards suppressed nuclear factor kappa B (NF kappa B) expression and reduced uptake of(125)I-oxLDL by 1.7- and 1.5-fold, respectively. Pravastatin also increased PPAR gamma levels and abolished NF kappa B activity in non-stimulated monocytes. Statin added to monocytes prior to or after treatment with nLDL or oxLDL significantly inhibited generation of matrix metalloproteinases (MMPs), monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor alpha (TNF- alpha). These data corroborate previous findings of the pleiotropic role of statins and also suggest the involvement of transcription factors such as PPAR gamma and NF kappa B in the modulation of the inflammatory processes by statins. Copyright 2002 Elsevier Science Ltd.}},
  author       = {{Zelvyté, Inga and Dominaitiene, Ruta and Crisby, Milita and Janciauskiene, Sabina}},
  issn         = {{1096-1186}},
  keywords     = {{lipoproteins; monocytes; Monocyte Chemoattractant Protein-1; NF kappa B; pravastatin}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{147--154}},
  publisher    = {{Academic Press}},
  series       = {{Pharmacological Research}},
  title        = {{Modulation of inflammatory mediators and ppargammaand nfkappab expression by pravastatin in response to lipoproteins in human monocytes in vitro.}},
  url          = {{http://dx.doi.org/10.1006/phrs.2001.0922}},
  doi          = {{10.1006/phrs.2001.0922}},
  volume       = {{45}},
  year         = {{2002}},
}